PRBCF yields 1052.63% · MRK yields 2.81%● Live data
📍 PRBCF pulled ahead of the other in Year 1
Combined, PRBCF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRBCF + MRK for your $10,000?
Precise Biometrics AB (publ) offers identification software for the secure authentication of people's identity in Europe, Asia, and the United States. It provides Precise YOUNiQ that verifies digital identity; Precise BioMatch Card, a fingerprint algorithm solution for identity authentication in smart cards; Precise BioMatch Mobile, a fingerprint algorithm solution for identity authentication in smartphones and tablets; and Precise BioLive, a fingerprint software that identifies a fake fingerprint. The company offers its products to sensor manufacturers, security companies, and system integrators, as well as finance, betting, healthcare, and transport sectors. Precise Biometrics AB (publ) was incorporated in 1997 and is headquartered in Lund, Sweden.
Full PRBCF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.